Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Drugs Aging ; 35(5): 467-476, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29651640

RESUMO

BACKGROUND: Prescription sleep medications are often utilized to manage sleep problems among older adults even though these drugs are associated with multiple risks. OBJECTIVE: The aim was to determine the prevalence and characteristics of new-onset compared to chronic sleep medication users and to examine factors associated with the conversion from new to chronic use. A secondary objective was to investigate the impact of sleep medications on health outcomes of injurious falls and patterns of healthcare utilization and expenditures. METHODS: A 25% random sample of adults ≥ 65 years with 3-year continuous AARP® Medicare Supplement medical and AARP® MedicareRx drug plan enrollment was utilized to identify new-onset and chronic sleep medication users. Prescription sleep medication drugs were defined using National Drug Codes (NDCs); falls or hip fractures were identified from diagnosis codes. New users had no sleep medication use in 2014, but initiated medication use in 2015; chronic users had at least one sleep medication prescription in 2014 and in 2015; both groups had follow-up through 2016. Characteristics associated with new users, new users who converted to chronic use, and chronic users were determined using multivariate logistic regression. Prevalence of falls, healthcare utilization and expenditures were regression adjusted. RESULTS: Among eligible insureds, 3 and 9% were identified as new-onset and chronic sleep medication users, respectively. New-onset sleep medication prescriptions were often associated with an inpatient hospitalization. The strongest characteristics associated with new users, those who converted to chronic use, and chronic users were sleep disorders, depression and opioid use. About 50% of new users had > 30 days' supply; 25% converted to chronic use with ≥ 90 days' supply. The prevalence of falls for new-onset users increased by 70% compared to a 22% increase among chronic users. CONCLUSION: New-onset and chronic sleep medication users were characterized by sleep disorders, depression and pain. Addressing the underlying problems associated with sleep problems among older adults may decrease the need for sleep medications and thus reduce the risk of sleep medication-related adverse events.


Assuntos
Transtornos do Sono-Vigília/tratamento farmacológico , Fatores Etários , Idoso , Prescrições de Medicamentos/economia , Feminino , Humanos , Masculino , Medicare , Pessoa de Meia-Idade , Medicamentos sob Prescrição/administração & dosagem , Medicamentos sob Prescrição/economia , Prevalência , Pontuação de Propensão , Estudos Retrospectivos , Sono/efeitos dos fármacos , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA